A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST).

2.50
Hdl Handle:
http://hdl.handle.net/10541/80241
Title:
A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST).
Authors:
Judson, Ian R; Leahy, Michael G; Whelan, Jeremy; Lorigan, Paul C ( 0000-0002-8875-2164 ) ; Verrill, Mark W; Grimer, Robert; Robinson, Martin
Abstract:
Gastrointestinal stromal tumour (GIST) is the commonest mesenchymal tumour to affect the gastrointestinal tract. Appropriate management requires accurate diagnosis and the skills of a multidisciplinary team. Surgery is the only curative treatment option and should be performed whenever feasible, by experienced personnel. For patients with advanced unresectable or metastatic disease, the receptor tyrosine kinase inhibitor imatinib offers effective therapy and can provide effective palliation for the majority of patients with this disease. The background to this recent development and a guideline for the management of GIST is proposed.
Affiliation:
Royal Marsden Hospital London UK.
Citation:
A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST). 2002, 6 (3):83-7 Sarcoma
Journal:
Sarcoma
Issue Date:
2002
URI:
http://hdl.handle.net/10541/80241
DOI:
10.1080/1357714021000045217
PubMed ID:
18521337
Type:
Article
Language:
en
ISSN:
1357-714X
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorJudson, Ian R-
dc.contributor.authorLeahy, Michael G-
dc.contributor.authorWhelan, Jeremy-
dc.contributor.authorLorigan, Paul C-
dc.contributor.authorVerrill, Mark W-
dc.contributor.authorGrimer, Robert-
dc.contributor.authorRobinson, Martin-
dc.date.accessioned2009-09-08T10:31:01Z-
dc.date.available2009-09-08T10:31:01Z-
dc.date.issued2002-
dc.identifier.citationA Guideline for the Management of Gastrointestinal Stromal Tumour (GIST). 2002, 6 (3):83-7 Sarcomaen
dc.identifier.issn1357-714X-
dc.identifier.pmid18521337-
dc.identifier.doi10.1080/1357714021000045217-
dc.identifier.urihttp://hdl.handle.net/10541/80241-
dc.description.abstractGastrointestinal stromal tumour (GIST) is the commonest mesenchymal tumour to affect the gastrointestinal tract. Appropriate management requires accurate diagnosis and the skills of a multidisciplinary team. Surgery is the only curative treatment option and should be performed whenever feasible, by experienced personnel. For patients with advanced unresectable or metastatic disease, the receptor tyrosine kinase inhibitor imatinib offers effective therapy and can provide effective palliation for the majority of patients with this disease. The background to this recent development and a guideline for the management of GIST is proposed.en
dc.language.isoenen
dc.subjectGastrointestinal Stromal Tumouren
dc.subjectCancer Metastasisen
dc.subjectTreatment Managementen
dc.subjectGuidelineen
dc.titleA Guideline for the Management of Gastrointestinal Stromal Tumour (GIST).en
dc.typeArticleen
dc.contributor.departmentRoyal Marsden Hospital London UK.en
dc.identifier.journalSarcomaen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.